The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus

Journal of Molecular Endocrinology

Volumn 34, Issue 1, 2005, Pages 107-118

  Kim, J ^a   Jia, L ^b   Stallcup, M R ^b   Coetzee, G A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; PROSTATE SPECIFIC ANTIGEN; PROTEIN P300;

5' UNTRANSLATED REGION; ACETYLATION; ARTICLE; CHROMATIN; DISEASE COURSE; ENZYME ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ACETYLATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; HISTONES; HUMANS; MALE; PHOSPHORYLATION; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 14544300650     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01701     Document Type: Article

References (33)

1. Aarnisalo P, Palvimo JJ & Janne OA 1998 CREB-binding protein in androgen receptor-mediated signaling. PNAS 95 2122-2127.
2. Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommum B, Trouche D & Haxel-Bellan A 1998 Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396 184-186.
3. Black BE, Vitto MJ, Gioeli D, Spencer A, Afshar N, Conaway MR, Weber MJ & Paschal BM 2004 Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Molecular Endocrinology 18 834-850.
4. Blok LJ, de Ruiter PE & Brinkmann AO 1998 Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 37 3850-3857.
5. Buchanan G, Irvine RA, Coetzee GA & Tilley WD 2001 Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Reviews 20 207-223.
6. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR & Goodman RH 1993 Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 855-859.
7. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G & Klocker H 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Research 54 5474-5478.
8. Debes JD, Schmidt LJ, Huang H & Tindall DJ 2002 p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Research 62 5632-5636.
9. Feldman BJ & Feldman D 2001 The development of androgen-independent prostate cancer. Nature Reviews Cancer 1 34-45.
10. Felinski EA & Quinn PG 1999 The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding. Journal of Biological Chemistry 274 11672-11678.
11. Fronsdal K, Engedal N, Slagsvold T & Saatcioglu F 1998 CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. Journal of Biological Chemistry 273 31853-31859.
12. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J, Hunt DF & Weber MJ 2002 Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. Journal of Biological Chemistry 277 29304-29314.
13. Giordano A & Avantaggiati ML 1999 p300 and CBP: partners for life and death. Journal of Cellular Physiology 181 218-230.
14. Jia L, Kim J, Shen H, Clark PE, Tilley WD & Coetzee GA 2003 Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms. Molecular Cancer Research 1 385-392.
15. Jia L, Choong CS, Ricciardelli C, Kim J, Tilley WD & Coetzee CA 2004 Androgen receptor signaling: mechanism of interleukin-6 inhibition. Cancer Research 64 2619-2626.
16. Kim J, Jia L, Tilley WD & Coetzee GA 2003 Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor. Nucleic Acids Research 31 6741-6747.
17. Kitabayashi I, Eckner R, Arany Z, Chiu R, Gachelin G, Livingston DM & Yokoyama KK 1995 Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. Embo Journal 14 3496-3509.
18. Korzus E, Torchia J, Rose DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK & Rosenfeld MG 1998 Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279 703-707.
19. Lee YH, Koh SS, Zhang X, Cheng X & Stallcup MR 2002 Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Molecular and Cellular Biology 22 3621-3632.
20. Louie MC, Yang HO, Ma AH, Xu W, Zou JX, Kung HJ & Chen HW 2003 Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. PNAS 100 2226-2230.
21. Lundblad JR, Kwok RP, Laurance ME, Harter ML & Goodman RH 1995 Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374 85-88.
22. Mayr B & Montminy M 2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Reviews. Molecular Cell Biology 2 599-609.
23. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J & Montminy MR 1996 The signal-dependent coactivator CBP is a nuclear target for pp90 RSK. Cell 86 465-474.
24. Nakajima T, Uchida C, Anderson SF, Parvin JD & Montminy M 1997 Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes and Development 11 738-747.
25. Nazareth LV & Weigel NL 1996 Activation of the human androgen receptor through a protein kinase A signaling pathway. Journal of Biological Chemistry 271 19900-19907.
26. Reinikainen P, Palvimo JJ & Janne OA 1996 Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137 4351-4357.
27. Sadar MD, Hussain M & Bruchovsky N 1999 Prostate cancer: molecular biology of early progression to androgen independence. Endocrine-Related Cancer 6 487-502.
28. Shang Y, Myers M & Brown M 2002 Formation of the androgen receptor transcription complex. Molecular Cell 9 601-610.
29. Shaywitz AJ & Greenberg ME 1999 CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annual Review of Biochemistry 68 821-861.
30. Struhl K, Kadosh D, Keaveney M, Kuras L & Moqtaderi Z 1998 Activation and repression mechanisms in yeast. Cold Spring Harbor Symposium on Quantitative Biology 63 413-421.
31. Ueda T, Mawji NR, Bruchovsky N & Sadar MD 2002 Ligand-independent activation of the androgen receptor by IL-6 and the role of the coactivator SRC-1 in prostate cancer cells. Journal of Biological Chemistry 277 38087-38094.
32. Weber MJ & Gioeli D 2004 Ras signaling in prostate cancer progression. Journal of Cellular Biochemistry 91 13-25.
33. Whyte P, Williamson NM & Harlow E 1989 Cellular targets for transformation by the adenovirus E1A proteins. Cell 56 67-75.